DE3787448D1 - Verwendung von Otiloniumbromid für die topische Anwendung im Gastrointestinaltrakt und entsprechende geeignete pharmazeutische Formulierung. - Google Patents

Verwendung von Otiloniumbromid für die topische Anwendung im Gastrointestinaltrakt und entsprechende geeignete pharmazeutische Formulierung.

Info

Publication number
DE3787448D1
DE3787448D1 DE87830386T DE3787448T DE3787448D1 DE 3787448 D1 DE3787448 D1 DE 3787448D1 DE 87830386 T DE87830386 T DE 87830386T DE 3787448 T DE3787448 T DE 3787448T DE 3787448 D1 DE3787448 D1 DE 3787448D1
Authority
DE
Germany
Prior art keywords
pharmaceutical formulation
gastrointestinal tract
otlonium
bromide
suitable pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE87830386T
Other languages
English (en)
Other versions
DE3787448T2 (de
Inventor
Alessandro Casini
Sandro Parti
Paolo Bucci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Menarini Industrie Farmaceutiche Riunite SRL
Original Assignee
Menarini Industrie Farmaceutiche Riunite SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Industrie Farmaceutiche Riunite SRL filed Critical Menarini Industrie Farmaceutiche Riunite SRL
Application granted granted Critical
Publication of DE3787448D1 publication Critical patent/DE3787448D1/de
Publication of DE3787448T2 publication Critical patent/DE3787448T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245Amino benzoic acid types, e.g. procaine, novocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Endoscopes (AREA)
  • Steroid Compounds (AREA)
DE87830386T 1986-11-04 1987-11-03 Verwendung von Otiloniumbromid für die topische Anwendung im Gastrointestinaltrakt und entsprechende geeignete pharmazeutische Formulierung. Expired - Fee Related DE3787448T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8609514A IT1216283B (it) 1986-11-04 1986-11-04 Utilizzazione di ottilonio bromuro (dci) per applicazione topica nel tratto gastro-intestinale e relativa formulazione farmaceutica appropriata per tale uso.

Publications (2)

Publication Number Publication Date
DE3787448D1 true DE3787448D1 (de) 1993-10-21
DE3787448T2 DE3787448T2 (de) 1994-01-13

Family

ID=11131395

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87830386T Expired - Fee Related DE3787448T2 (de) 1986-11-04 1987-11-03 Verwendung von Otiloniumbromid für die topische Anwendung im Gastrointestinaltrakt und entsprechende geeignete pharmazeutische Formulierung.

Country Status (8)

Country Link
US (1) US4978772A (de)
EP (1) EP0270503B1 (de)
JP (1) JP2514670B2 (de)
AT (1) ATE94388T1 (de)
CA (1) CA1311419C (de)
DE (1) DE3787448T2 (de)
ES (1) ES2058138T3 (de)
IT (1) IT1216283B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100503889B1 (ko) * 2002-07-20 2005-07-26 한국과학기술연구원 옥틸로늄 브로마이드를 함유하는 항암제 흡수 증진제
TR201111221T2 (tr) * 2009-02-12 2012-02-21 Abd� �Brah�M �La� Sanay� Ve T�Caret Anon�M ��Rket�@ Simetikon ve otilonyumun farmasötik kombinasyonları.
EP2481403A1 (de) 2011-02-01 2012-08-01 Deva Holding Anonim Sirketi Pharmazeutische kombination von Otilonium mit Trimebutine
EP2481395A1 (de) 2011-02-01 2012-08-01 Deva Holding Anonim Sirketi Sachet, Brausetabletten und Sirup Trockensubstanz Formulierungen von Otilonium
US20180311201A1 (en) 2015-06-12 2018-11-01 Santa Farma ?Laç Sanay? A. ?. Oral pharmaceutical composition comprising otilonium bromide and simethicone with certain bulk density and improved dissolution characteristics

Also Published As

Publication number Publication date
US4978772A (en) 1990-12-18
DE3787448T2 (de) 1994-01-13
ES2058138T3 (es) 1994-11-01
JP2514670B2 (ja) 1996-07-10
JPS63130530A (ja) 1988-06-02
EP0270503B1 (de) 1993-09-15
EP0270503A2 (de) 1988-06-08
IT8609514A0 (it) 1986-11-04
CA1311419C (en) 1992-12-15
ATE94388T1 (de) 1993-10-15
EP0270503A3 (en) 1990-04-18
IT1216283B (it) 1990-02-22

Similar Documents

Publication Publication Date Title
NO892985L (no) Nytt, fast og poroest enhetselement omfattende mikropartikler og/eller nanopartikler og fremgangsmaate for fremstilling derav.
DE3883985D1 (de) Ärztliches instrument und dessen herstellung.
UY23909A1 (es) Procedimiento para la preparacion de 6- derivados sustitutivos del acido micofenolico
IT1224795B (it) Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
NO874869L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO173653C (no) Analogifremgangsmaate for fresmstilling av terapeutisk aktive 6-benzoksazinyl-og 6-benzotianzinyl-2,3,4,5-tetrahydropyridazin-3-oner
PT533281E (pt) A utilizacao sw citrato de ranitidina bismuto e em combinacao com claritromicina ou claritromicina e tetraciclina no fabrico de um medicamento para tratamento de perturbacoes gastrointestinais
IT8868118A0 (it) Composizione e procedimento per il trattamento e la cura dei capelli
DE3787448D1 (de) Verwendung von Otiloniumbromid für die topische Anwendung im Gastrointestinaltrakt und entsprechende geeignete pharmazeutische Formulierung.
PT83556A (de) Biologisch aktive derivate des human-gama-interferons ihre herstellung und arzneimittel die solche derivate enthalten
DK317285D0 (da) Farmakologisk virksomme (pyrrol-1-yl)-phenyl-dihydropyridazinoner ogfremgangsmaade til fremstilling heraf
IT1157217B (it) Procedimento e dispositivo per l'ossigenazione del sangue
FR2595247B1 (fr) Utilisation en cosmetologie d'extraits de mucus ou de suc digestif de gasteropodes et preparation de ces extraits
FR2597995B1 (fr) Dispositif d'eveil programmable en fonction du rythme biologique personnel
AU6360486A (en) Procedure for obtaining the preparation for the treatment of the disease psoriasis; drug for the treatment of psoriasis and its application
FI861093A0 (fi) Bioelektrisk patientmonitor.
DE3582180D1 (de) Lebender attenuierter menschlicher rotavirus-impfstoff und herstellung desselben.
ATE110566T1 (de) Topische vaginal-verwendung von lysin p- isobutylphenylpropionat zur entzündungshemmenden behandlung.
BE778979A (fr) Application en therapeutique de l'association de l'ethchlorvynol et de la diphenhydramine
GR862563B (en) Medicament and cosmetic for the treatment of psoriasis or other skin diseases and haemorrhoids
IT8500516V0 (it) Attrezzo da ginnastica-verticallinea-per prevenire,curare, migliorare la salute e l'aspetto del corpo umano
FR2599974B1 (fr) Utilisation de la phospholipase a2, association et composition therapeutiques en resultant
IT8521025A0 (it) Dispositivo per l'intubazione bronchiale selettiva e la ventilazione separata dei due polmoni in anestesia, terapia intensiva e rianimazione.
IL85508A0 (en) Benzylaminoaryl-dihydropyridinelactones,their preparation and their use in medicaments
FI893001A0 (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 1,2-bensisoxazol-3-yl- och 1,2-bensisotiazol -3-ylderivat.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee